Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports

BACKGROUND: Musculoskeletal manifestations are common extraintestinal manifestations of inflammatory bowel disease. Tofacitinib is a Janus kinase inhibitor approved for treating rheumatoid arthritis and ulcerative colitis. There are limited data on the efficacy of tofacitinib in managing inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Momen Majumder, Muhammad Shoaib, Haq, Syed Atiqul, Rasker, Johannes J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976468/
https://www.ncbi.nlm.nih.gov/pubmed/36855206
http://dx.doi.org/10.1186/s13256-023-03796-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976468/
https://www.ncbi.nlm.nih.gov/pubmed/36855206
http://dx.doi.org/10.1186/s13256-023-03796-2

Ejemplares similares